185 related articles for article (PubMed ID: 28982855)
1. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
[TBL] [Abstract][Full Text] [Related]
3. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer.
Chen W; Zou P; Zhao Z; Chen X; Fan X; Vinothkumar R; Cui R; Wu F; Zhang Q; Liang G; Ji J
Redox Biol; 2016 Dec; 10():78-89. PubMed ID: 27697670
[TBL] [Abstract][Full Text] [Related]
5. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells.
Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F
Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.
Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L
PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
[TBL] [Abstract][Full Text] [Related]
8. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829
[TBL] [Abstract][Full Text] [Related]
9. Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer.
Chen X; Dai X; Zou P; Chen W; Rajamanickam V; Feng C; Zhuge W; Qiu C; Ye Q; Zhang X; Liang G
Br J Pharmacol; 2017 May; 174(10):1131-1146. PubMed ID: 28255993
[TBL] [Abstract][Full Text] [Related]
10. Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38.
Nikolova B; Semkova S; Tsoneva I; Stoyanova E; Lefterov P; Lazarova D; Zhelev Z; Aoki I; Higashi T; Bakalova R
Anticancer Res; 2020 Sep; 40(9):5159-5170. PubMed ID: 32878804
[TBL] [Abstract][Full Text] [Related]
11. EF24 induces ferroptosis in osteosarcoma cells through HMOX1.
Lin H; Chen X; Zhang C; Yang T; Deng Z; Song Y; Huang L; Li F; Li Q; Lin S; Jin D
Biomed Pharmacother; 2021 Apr; 136():111202. PubMed ID: 33453607
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.
Wu J; Wu S; Shi L; Zhang S; Ren J; Yao S; Yun D; Huang L; Wang J; Li W; Wu X; Qiu P; Liang G
Eur J Med Chem; 2017 Jan; 125():1321-1331. PubMed ID: 27886548
[TBL] [Abstract][Full Text] [Related]
13. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S
Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878
[TBL] [Abstract][Full Text] [Related]
14. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Yang CH; Yue J; Sims M; Pfeffer LM
PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
Alexandre J; Nicco C; Chéreau C; Laurent A; Weill B; Goldwasser F; Batteux F
J Natl Cancer Inst; 2006 Feb; 98(4):236-44. PubMed ID: 16478742
[TBL] [Abstract][Full Text] [Related]
16. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y
Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101
[TBL] [Abstract][Full Text] [Related]
19. The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells.
He Y; Li W; Zhang J; Yang Y; Qian Y; Zhou D
Curr Cancer Drug Targets; 2021; 21(7):608-618. PubMed ID: 33655859
[TBL] [Abstract][Full Text] [Related]
20. Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.
Liang Y; Yin D; Hou L; Zheng T; Wang J; Meng X; Lu Z; Song X; Pan S; Jiang H; Liu L
PLoS One; 2011; 6(8):e23908. PubMed ID: 21901145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
